You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

eyp001a

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis B, Chronic Trial in Hong Kong, Korea, Republic of, Taiwan (EYP001a, Entecavir, Pegylated interferon alpha2a)

Active, not recruiting
  • Hepatitis B, Chronic
  • EYP001a
  • +2 more
  • Hong Kong, Hong Kong
  • +5 more
Sep 27, 2021

Hepatitis B, Chronic Trial in Worldwide (EYP001a, Placebo, Entecavir)

Active, not recruiting
  • Hepatitis B, Chronic
  • EYP001a
  • +3 more
  • Brisbane, Australia
  • +17 more
May 12, 2021

NASH - Nonalcoholic Steatohepatitis, Healthy Trial in Randwick (EYP001a)

Completed
  • NASH - Nonalcoholic Steatohepatitis
  • Healthy
  • EYP001a
  • Randwick, New South Wales, Australia
    ENYO Pharma clinical site
Sep 24, 2020

Non-alcoholic Steatohepatitis Trial in Worldwide (EYP001a, Placebo)

Completed
  • Non-alcoholic Steatohepatitis
  • EYP001a
  • Placebo
  • North Little Rock, Arkansas
  • +41 more
Sep 13, 2021

Hepatitis B, Chronic Trial in Worldwide (EYP001a, Placebo, Entecavir)

Completed
  • Hepatitis B, Chronic
  • EYP001a
  • +3 more
  • Sydney, New South Wales, Australia
  • +8 more
Aug 20, 2018

Hepatitis B, Chronic Trial in Groningen (EYP001a)

Completed
  • Hepatitis B, Chronic
  • EYP001a
  • Groningen, Netherlands
    PRA-EDS
Mar 2, 2018

Healthy Trial (EYP001a, Placebo)

Completed
  • Healthy
  • EYP001a
  • Placebo
  • (no location specified)
Apr 11, 2017